Accessibility navigation


Trajectories of depression symptom change during and following treatment in adolescents with unipolar major depression

Davies, S. E., Neufeld, S. A. S., Sprang, E., Schweren, L., Keivit, R., Fonagy, P., Dubicka, B., Kelvin, R., Midgley, N., Reynolds, S., Target, M., Wilkinson, P., Harmelen, A. L. and Goodyer, I. M. (2019) Trajectories of depression symptom change during and following treatment in adolescents with unipolar major depression. Journal of Child Psychology and Psychiatry. ISSN 1469-7610

[img]
Preview
Text (Open Access) - Published Version
· Available under License Creative Commons Attribution.
· Please see our End User Agreement before downloading.

705kB

It is advisable to refer to the publisher's version if you intend to cite from this work. See Guidance on citing.

To link to this item DOI: 10.1111/jcpp.13145

Abstract/Summary

Objective To classify a cohort of depressed adolescents recruited to the UK IMPACT trial, according to trajectories of symptom change. We examined for predictors and compared the data‐driven categories of patients with a priori operational definitions of treatment response. Method Secondary data analysis using growth mixture modelling (GMM). Missing data were imputed. Trajectories of self‐reported depressive symptoms were plotted using scores taken at six nominal time points over 86 weeks from randomisation in all 465 patients. Results A piecewise GMM categorised patients into two classes with initially similar and subsequently distinct trajectories. Both groups had a significant decline in depressive symptoms over the first 18 weeks. Eighty‐four per cent (84.1%, n = 391) of patients were classed as ‘continued‐improvers’ with symptoms reducing over the duration of the study. A further class of 15.9% (n = 74) of patients were termed ‘halted‐improvers’ with higher baseline depression scores, faster early recovery but no further improvement after 18 weeks. Presence of baseline comorbidity somewhat increased membership to the halted‐improvers class (OR = 1.40, CI: 1.00–1.96). By end of study, compared with classes, a clinical remission cut‐off score (≤27) and a symptom reduction score (≥50%) indexing treatment response misclassified 15% and 31% of cases, respectively. Conclusions A fast reduction in depressive symptoms in the first few weeks of treatment may not indicate a good prognosis. Halted improvement is only seen after 18 weeks of treatment. Longitudinal modelling may improve the precision of revealing differential responses to treatment. Improvement in depressive symptoms may be somewhat better in the year after treatment than previously considered.

Item Type:Article
Refereed:Yes
Divisions:Faculty of Life Sciences > School of Psychology and Clinical Language Sciences > Department of Psychology
ID Code:87114
Uncontrolled Keywords:Pediatrics, Perinatology, and Child Health, Developmental and Educational Psychology, Psychiatry and Mental health
Publisher:Wiley

Downloads

Downloads per month over past year

University Staff: Request a correction | Centaur Editors: Update this record

Page navigation